A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness Professionals ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

It's an important reminder that many supplements are not regulated and therefore can sneak in potentially harmful ingredients ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Obesity is widely recognised as one of the leading issues in our society. According to UK Government data, it costs the NHS ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

Certain supplements are said to boost your metabolism and act as natural fat burners. But do they work? Find out what the ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

New re­search from the Uni­ver­si­ty of North Car­oli­na-Chapel Hill found that No­vo Nordisk’s weight loss drug may help ...

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...